M&A Deal Summary |
|
|---|---|
| Date | 2021-07-29 |
| Target | CryoLife - PerClot Polysaccharide Hemostatic System Certain Assets |
| Sector | Life Science |
| Buyer(s) | Baxter International |
| Sellers(s) | Artivion |
| Deal Type | Divestiture |
| Deal Value | 61M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1931 |
| Sector | Medical Products |
| Employees | 60,000 |
| Revenue | 14.8B USD (2023) |
Baxter International develops, manufactures and markets drugs and medical products for people with a variety of medical conditions. Baxter's operations are comprised of the BioScience and Medical Products segments. The BioScience business processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines. The Medical Products business manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. The business also provides products and services related to pharmacy compounding, drug formulation and packaging technologies. In addition, the Medical Products business provides products and services to treat end-stage renal disease, or irreversible kidney failure. Baxter International was founded in 1931 and is based in Deerfield, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 19 of 20 |
| Sector (Life Science) | 4 of 4 |
| Type (Divestiture) | 6 of 6 |
| State (Georgia) | 1 of 1 |
| Country (United States) | 13 of 14 |
| Year (2021) | 1 of 2 |
| Size (of disclosed) | 16 of 17 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-12-02 |
sanofi-aventis U.S.
United States Seprafilm Adhesion Barrier provides prevention products, hemostats, and sealants are important tools surgeons use to manage intraoperative bleeding and reduce adhesions. |
Buy | $350M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-09-02 |
Hill-Rom
Chicago, Illinois, United States Hill-Rom manufactures and provides medical technologies and related services for the health care industry. Hill-Rom offers patient care systems, safe mobility and handling solutions, and non-invasive therapeutic products for various acute and chronic medical conditions, medical equipment rentals, surgical products, and information technology solutions. Hill-Rom was founded in 1915 and is based in Chicago, Illinois. |
Buy | $12.4B |
| Category | Company |
|---|---|
| Founded | 1984 |
| Sector | Medical Products |
| Employees | 1,500 |
| Revenue | 354M USD (2023) |
Artivion is a manufacturer, processor, and distributor of implantable living tissues and medical devices used in cardiac and vascular surgical procedures. Artivion was incorporated in 1984 and is based in Kennesaw, Georgia.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 4 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 4 of 4 |
| State (Georgia) | 1 of 1 |
| Country (United States) | 4 of 4 |
| Year (2021) | 1 of 1 |
| Size (of disclosed) | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-09-02 |
Ascyrus Medical
Boca Raton, Florida, United States Ascyrus Medical LLC is a developer of the Ascyrus Medical Dissection Stent (AMDS™), aortic arch remodeling device used for the treatment of acute Type A aortic dissections. Ascyrus Medical is based in Boca Raton, Florida. |
Buy | $200M |
